Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: J Neurol

Search In Journal Title:

Abbravation: Journal of Neurology

Search In Journal Abbravation:

Publisher

Springer Berlin Heidelberg

Search In Publisher:

DOI

10.1007/978-3-540-30542-2_31

Search In DOI:

ISSN

1432-1459

Search In ISSN:
Search In Title Of Papers:

Domainspecific versus generalized cognitive scree

Authors: Nele Demeyere M J Riddoch E D Slavkova K Jones I Reckless P Mathieson G W Humphreys
Publish Date: 2015/11/20
Volume: 263, Issue: 2, Pages: 306-315
PDF Link

Abstract

Cognitive assessments after stroke are typically short form tests developed for dementia that generates pass/fail classifications eg the MoCA The Oxford Cognitive Screen OCS provides a domainspecific cognitive profile designed for stroke survivors This study compared the use of the MoCA and the OCS in acute stroke with respect to symptom specificity and aspects of clinical utility A crosssectional study with a consecutive sample of 200 stroke patients within 3 weeks of stroke completing MoCA and OCS Demographic data lesion side and Barthel scores were recorded Inclusivity was assessed in terms of completion rates and reasons for noncompletion were evaluated The incidence of cognitive impairments on both the MoCA and OCS subdomains was calculated and differences in stroke specificity cognitive profiles and independence of the measures were addressed The incidence of acute cognitive impairment was high 76  of patients were impaired on MoCA and 86  demonstrated at least one impairment on the cognitive domains assessed in the OCS OCS was more sensitive than MoCA overall 87 vs 78  sensitivity and OCS alone provided domainspecific information on prevalent poststroke cognitive impairments neglect apraxia and reading/writing ability Unlike the MOCA the OCS was not dominated by left hemisphere impairments but gave differentiated profiles across the contrasting domains The OCS detects important cognitive deficits after stroke not assessed in the MoCA it is inclusive for patients with aphasia and neglect and it is less confounded by cooccurring difficulties in these domainsFollowing stroke cognitive deficits are frequent 1 2 3 4 predictive of recovery 5 6 7 8 9 10 11 12 and interfere with rehabilitation eg due to poor comprehension or spatial attention Cognitive deficits after stroke are also associated with a reduced quality of life 13 14 15 and depression 8 Due to their prevalence and importance early detection is required to facilitate rehabilitationTo facilitate early detection short generalized cognitive screening tools are increasingly adopted The Montreal Cognitive Assessment MoCA 16 17 is one tool which is freely available and easy to administer returning a pass/fail generalized cognition score Though developed for dementia the MoCA has been shown to have better sensitivity in detecting poststroke cognitive impairments than the traditionally used MiniMental Status Examination MMSE 18 19 20 21 However neither the MMSE nor the MOCA assesses common poststroke domainspecific impairments including aphasia visual loss visuospatial inattention neglect apraxia and reading/writing problems Furthermore performance on the tests that are included can be confounded by cooccurring problems For example arguably all of the MoCA subtests require substantial verbal abilities and aphasic patients will fail tests of nonlanguage domains eg memory because of language impairments Similarly patients can fail subtests because they neglect one side of the page eg in the trail making testClinical guidelines emphasize the need to assess performance across different domains of cognition after stroke eg “attention memory spatial awareness apraxia perception”—UK National Institute for Clinical Excellence guideline for stroke care 2013 highlighting the need for domainspecific cognitive assessments Detailed neuropsychological examinations can detect specific cognitive impairments 2 22 Not surprisingly when comparing a short MoCA screen to a detailed battery of neuropsychological assessments the detection rate of cognitive problems was demonstrably lower in the MOCA 23 However detailed batteries are often impractical not designed for acute stroke and very time consuming and need trained examiners for administration who cannot routinely see all patientsA recent review and metaanalysis of test accuracy of cognitive screening tests concluded that there was no clearly superior screening test comparing MoCA ACER MMSE and CAMCOG It should be noted however that none of the screens were strokespecific and the studies that were included focussed on generalized impairments equating cognitive impairments to dementia In addition only 11 of the 35 included studies were conducted in acute stroke 24The Oxford Cognitive Screen—OCS 25 was specifically developed to measure domainspecific cognitive deficits in acute stroke It provides a short cognitive screen covering five cognitive domains including the assessment of important and commonly found strokespecific cognitive problems such as unilateral neglect aphasia and apraxia The reporting structure emphasizes the domain specificity of problems going beyond an overall pass/fail outcome It also goes beyond other measures by being designed to avoid confounding effects within the separate cognitive domains providing ‘aphasia and neglect friendly’ measures of performanceIn this study we compared domainspecific cognitive screening OCS with generalized screening provided through the MoCA in an acute stroke population We examined 1 how well the tools detected strokespecific cognitive impairments and 2 their clinical utility in terms of patient inclusion and generating accurate cognitive profiles for patients with cooccurring deficitsThe Oxford Cognitive Screen OCS is a recently developed strokespecific cognitive screen see 20 for normative data validation and reliability and sensitivity measures of the OCS The OCS is structured around five domains 1 attention and executive function 2 language 3 memory 4 number processing and 5 praxis The tests were designed to be inclusive and uncontaminated by aphasia and neglect when respectively language and spatial attention are not assessed The test is freely available for clinical use and licensed through the University of Oxford’s technology transfer office http//wwwocstestorg The OCS as a domainspecific assessment provides a ‘visual snapshot’ of a patient’s cognitive profile for easy domain level see 25


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Toothbrushing-induced seizures at onset of cryptogenic partial epilepsy: a case report
  2. Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease
  3. Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy
  4. Walter Rudolf Hess (1881–1973)
  5. Current concepts and future approaches to vestibular rehabilitation
  6. Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson’s disease
  7. Vestibular animal models: contributions to understanding physiology and disease
  8. Primary leptomeningeal lymphoma of the cauda equina: a rare cause of radiculopathy
  9. DWI and FLAIR imaging in herpes simplex encephalitis: a comparative and topographical analysis
  10. Interferon beta in secondary progressive multiple sclerosis
  11. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity
  12. Diaphragm of the internal carotid artery: a novel cause of pulsatile tinnitus
  13. Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry
  14. Tolvaptan treatment of severe stroke-like symptoms and bilateral subcortical diffusion restriction due to syndrome of inappropriate secretion of ADH after polytrauma
  15. Tolvaptan treatment of severe stroke-like symptoms and bilateral subcortical diffusion restriction due to syndrome of inappropriate secretion of ADH after polytrauma
  16. Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T
  17. Neurological complications of Behçet’s syndrome
  18. Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy’s disease)
  19. Meningitis–retention syndrome
  20. APOE genotypes in Greek multiple sclerosis patients: no effect on the MS Severity Score
  21. Early MRI findings in Creutzfeldt-Jakob disease
  22. Causes and characteristics of horizontal positional nystagmus
  23. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson’s disease
  24. Mastication-induced vertigo and nystagmus
  25. Need for extensive diagnostic work-up for patients with lacunar stroke
  26. Low testosterone and myasthenia gravis in males: a national record-linkage study
  27. Plasma levels of nitric oxide and stroke outcome
  28. High field MR imaging and 1 H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis
  29. Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
  30. Cesare Vigna (1819–1892)
  31. Cesare Vigna (1819–1892)
  32. Aquaporin-4 seropositivity in a patient with coeliac disease but normal neurological examination and imaging
  33. Repetitive magnetic stimulation A novel therapeutic approach for myofascial pain syndrome
  34. Downbeat positioning nystagmus is a common clinical feature despite variable phenotypes in an FHM1 family
  35. Psychological interventions for migraine: a systematic review
  36. Respiratory dysfunction in Charcot–Marie–Tooth disease type 1A
  37. Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation
  38. Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1
  39. Spinocerebellar ataxia type 17 in a patient from an Indian kindred
  40. ‘Switching off’ SUNCT by sudden head movement: a new symptom
  41. A clinical, radiological and outcome study of status epilepticus from India
  42. The impact of subthalamic deep brain stimulation on caregivers of Parkinson’s disease patients: an exploratory study
  43. Management of respiratory symptoms in ALS
  44. Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease
  45. Opsoclonus–myoclonus–ataxia syndrome and HIV seroconversion
  46. Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study
  47. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci
  48. Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer’s disease case
  49. Recovery from mild traumatic brain injury
  50. Modafinil for Parkinson’s disease fatigue
  51. Diagnosis and treatment of upper limb apraxia
  52. Familial aggregation in atypical Parkinson’s disease: a case control study in multiple system atrophy and progressive supranuclear palsy
  53. Thymectomy: role in the treatment of myasthenia gravis
  54. Long-term EMG recordings differentiate between parkinsonian and essential tremor
  55. Isolated recurrent myelitis in a 7-year-old child with serum aquaporin-4 IgG antibodies
  56. Cortical thinning in drug-naive Parkinson’s disease patients with depression
  57. Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease
  58. Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China
  59. Tic disorders: from pathophysiology to treatment
  60. Parkinson’s disease: news on tremor, subthalamic stimulation and impulse control disorders
  61. The use of multiattribute decision models in evaluating triptan treatment options in migraine
  62. Psychiatric disorders in idiopathic-isolated focal dystonia
  63. Multiple sclerosis imaging: recent advances
  64. Hemifacial presentation of mitochondrial myopathy
  65. Teleneurology in stroke management: costs of service in different organizational models
  66. Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS
  67. Cerebral blood flow abnormalities in patients with neurally mediated syncope
  68. Specific electron transport chain abnormalities in amyotrophic lateral sclerosis
  69. Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
  70. Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients’ perspectives
  71. Bladder dysfunction in subacute combined degeneration
  72. Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis
  73. Missense exchanges in the TTBK2 gene mutated in SCA11
  74. Diffusion tensor imaging reveals widespread white matter abnormalities in children and adolescents with myotonic dystrophy type 1
  75. Prior medical conditions and the risk of amyotrophic lateral sclerosis
  76. An epidemiological study of neuromyelitis optica in Cuba
  77. Brachial neuritis caused by varicella-zoster diagnosed by changes in brachial plexus on MRI
  78. Subthalamic nucleus stimulation in Parkinson’s disease
  79. Dopaminergic medication does not improve stepping responses following backward and forward balance perturbations in patients with Parkinson’s disease
  80. Novel EXOSC3 mutation causes complicated hereditary spastic paraplegia
  81. A genome wide linkage disequilibrium screen in Parkinson’s disease
  82. Differential effect of Huntington's and Parkinson's diseases in programming motor sequences of varied lengths
  83. Accuracy of subjective and objective handwriting assessment for differentiating Parkinson’s disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study
  84. The utility of F wave chronodispersion in lumbosacral radiculopathy
  85. Accuracy of subjective and objective handwriting assessment for differentiating Parkinson’s disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study
  86. Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated?
  87. Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?
  88. Paroxysmal raised intracranial pressure associated with spinal meningeal cysts
  89. The relationship between impairment of voluntary movements and cognitive impairment in Huntington’s disease
  90. Long-term domain-specific improvement following poor grade aneurysmal subarachnoid hemorrhage

Search Result: